Literature DB >> 18536450

[The study on the preparation and spectroscopic properties of hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex].

Yi-Min Zhang1, Xiao Li, Cong-Shan Sun, Chun-Feng Chen.   

Abstract

The interaction of glipizide and hydroxypropyl-pcyclodextrin was investigated in the present paper. The stability constant and molar ratio of glipizide and hydroxypropyl-beta-cyclodextrin was calculated from the phase soluility diagram. The solid state inclusion complex of hydroxypropyl-beta-cyclodextrin/glipizide prepared by neutralization method was characterized by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and powder X-ray diffraction (XRD). It was found that the phase solubility diagram of the HP-beta-CD solution showed a typical AL-type, suggesting the formation of a soluble complex of 1 : 1 molar ratio, and the stability constant was 359 L x mol(-1) at 25 degrees C. The spectra of IR, thermograph of DSC and XRD pattern of the inclusion complex were remarkably different from the glipizide and hydroxypropyl-beta-cyclodextrin/glipizide physical mixture, and indicated that hydroxypropyl-beta-cyclodextrin/glipizide inclusion complex displayed amorphous characteristic. The experiment of solubility of inclusion complex indicated that the solubility of inclusion complex increased 25-fold.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536450

Source DB:  PubMed          Journal:  Guang Pu Xue Yu Guang Pu Fen Xi        ISSN: 1000-0593            Impact factor:   0.589


  2 in total

1.  Investigation of molecular aggregation mechanism of glipizide/cyclodextrin complexation by combined experimental and molecular modeling approaches.

Authors:  Tianhe Huang; Qianqian Zhao; Yan Su; Defang Ouyang
Journal:  Asian J Pharm Sci       Date:  2018-12-08       Impact factor: 6.598

2.  Design, optimization and evaluation of glipizide solid self-nanoemulsifying drug delivery for enhanced solubility and dissolution.

Authors:  Rajendra Narayan Dash; Habibuddin Mohammed; Touseef Humaira; Devi Ramesh
Journal:  Saudi Pharm J       Date:  2015-02-19       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.